Jazz Pharmaceuticals (JAZZ)
NASDAQ: JAZZ
· Real-Time Price · USD
127.80
-1.79 (-1.38%)
At close: Sep 25, 2025, 3:59 PM
127.79
-0.01%
After-hours: Sep 25, 2025, 04:18 PM EDT
-1.38% (1D)
| Bid | 125.5 |
| Market Cap | 7.75B |
| Revenue (ttm) | 4.09B |
| Net Income (ttm) | -404.84M |
| EPS (ttm) | -6.97 |
| PE Ratio (ttm) | -18.34 |
| Forward PE | 6.02 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 131 |
| Volume | 443,840 |
| Avg. Volume (20D) | 741,877 |
| Open | 128.99 |
| Previous Close | 129.59 |
| Day's Range | 126.91 - 129.25 |
| 52-Week Range | 95.49 - 148.06 |
| Beta | 0.24 |
| Ex-Dividend Date | n/a |
About JAZZ
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol JAZZ
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for JAZZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsJazz Pharmaceuticals is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-8.75%
Jazz Pharmaceuticals shares are trading lower afte...
Unlock content with
Pro Subscription
4 months ago
-5.94%
Jazz Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 financial results and cut its FY25 adjusted EPS guidance.
